Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Mar;48(3):1051-4.
doi: 10.1128/AAC.48.3.1051-1054.2004.

Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers

I M Rigter  1 , H G Schipper, R P Koopmans, H J M van Kan, H W Frijlink, P A Kager, H-J Guchelaar
Affiliations
Clinical Trial

Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers

I M Rigter et al. Antimicrob Agents Chemother. 2004 Mar.

Abstract

This study of healthy volunteers shows that the relative bioavailability of albendazole formulations that use arachis oil-polysorbate 80 or hydroxypropyl-beta-cyclodextrin as an excipient was enhanced 4.3- and 9.7-fold compared to the results seen with commercial tablets. Administration of macrogol suppositories did not result in measurable plasma concentrations of albendazole sulfoxide.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
ABZSX concentration-versus-time curves for subject J after administration of a single dose of 800 mg of albendazole (given as a cyclodextrin solution, an arachis oil-polysorbate 80 suspension, a tablet, and a suppository).
FIG. 2.
FIG. 2.
Cmax and AUC0- 52 values for ABZX in 10 healthy subjects (subjects a to j) after administration of a single dose of 800 mg of albendazole (given as a tablet, an arachis oil-polysorbate 80 suspension, and a cyclodextrin solution).
See this image and copyright information in PMC

References

    1. Awadzi, K., M. Hero, N. O. Opoku, D. W. Büttner, P. A. Coventry, M. A. Prime, M. L. E. Orme, and G. Edwards. 1994. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Trop. Med. Parasitol. 45:203-208. - PubMed
    1. Davis, A., H. Dixon, and Z. S. Pawlowski. 1989. Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). Bull. W. H. O. 67:503-508. - PMC - PubMed
    1. del Estal, J. L., A. I. Alvarez, C. Villaverde, P. Coronel, S. Fabra, and J. G. Prieto. 1991. Effect of surfactants on albendazole absorption. J. Pharm. Biomed. Anal. 9:1161-1164. - PubMed
    1. del Estal, J. L., A. I. Alvarez, C. Villaverde, A. Justel, and J. G. Prieto. 1994. Increased systemic bioavailability of albendazol when administered with surfactants in rats. Int. J. Pharm. 102:257-260.
    1. del Estal, J. L., A. I. Alvarez, C. Villaverde, and J. G. Prieto. 1993. Comparative effects of anionic, natural bile acid surfactants and mixed micelles on the intestinal absorption of the anthelmintic albendazole. Int. J. Pharm. 91:105-109.

LinkOut - more resources